Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Anti-Asthmatics And COPD Drugs Market Report 2024

AntiAsthmatics And COPD Drugs Global Market Report 2023 – By Type (Antihistamine Drugs, longacting ß2agonists (LABA), Inhaled corticosteriods, Shortacting muscarinic receptor antagonists (SAMAs), Other AntiAsthmatics And COPD Drugs (including Combinations)), By Drug Class (Bronchodilators, Antiinflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, ECommerce) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Anti-Asthmatics And COPD Drugs Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Anti-asthmatic and chronic obstructive pulmonary disease refers to drugs that are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings.

The main classes of drugs in anti-asthmatics and chronic obstructive pulmonary disease (COPD) are bronchodilators, anti-inflammatory drugs, monoclonal antibodies, and combination drugs. A bronchodilator, also known as bronchiolitis, is a drug that stimulates the bronchi and bronchioles, reducing respiratory airway resistance and boosting lung airflow. The different types include anti-histamine drugs, long-acting ß2-agonists (LABA), inhaled corticosteroids, short-acting muscarinic receptor antagonists (Samas), and other anti-asthmatics and COPD drugs (including combinations). The several end users include asthma patients, and COPD patients and are distributed through various channels such as hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce.

The global anti-asthmatics and COPD drugs market is segmented –

1) By Type: Anti-histamine Drugs, long-acting ß2-agonists (LABA), Inhaled corticosteriods, Short-acting muscarinic receptor antagonists (SAMAs), Other Anti-Asthmatics And COPD Drugs (including Combinations)

2) By Drug Class: Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs

3) By End User: Asthma Patients, COPD Patients

4) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce

The global anti-asthmatics and copd drugs market size will grow from $88.20 billion in 2022 to $94.10 billion in 2023 at a compound annual growth rate (CAGR) of 6.7% . The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global anti-asthmatics and copd drugs is expected to grow to $117.36 billion in 2027 at a CAGR of 5.7% .

Modifiable risk factors including smoking, lack of physical exercise, and unhealthy eating habits drive the Asthma and COPD drugs market. Even though there is a decreasing trend in smoking prevalence globally, developing countries such as China, India, Indonesia, and Nigeria among others have increasing smoking prevalence. For instance, the number of tobacco smokers is set to increase by 24 million in Indonesia and by 7 million in Nigeria by 2025, and more than 40% of global cigarette consumption is concentrated in China. Consumption of fats including saturated fatty acids which is a risk factor for Asthma and COPD is more in high-income countries including the USA and Europe. According to WHO, in developed countries, more than 35% of total energy requirement is derived from fats when compared to <20% in low-income countries, and <25% in lower-middle-income countries.

Major players in the anti-asthmatics and COPD drugs market are Novartis AG, Merck & Co., GlaxoSmithKline, Boehringer Ingelheim Gmbh, AstraZeneca, Roche, Teva Pharmaceutical, Vectura, Pfizer and Abbott .

Developing the patent expiration of innovator drugs is restricting the anti-asthmatics and COPD drugs market. Due to patent expiration, generic drugs are entering the market which is inexpensive when compared to innovator drugs. For example, the patent for roflumilast tablets expired in January 2020. Daliresp, roflumilast tablets are a prescription medication meant for patients with severe COPD to reduce the number of episodes of COPD. Therefore, developing patent expiration of innovator drugs is expected to hamper the growth of the anti-asthmatics and COPD drugs market in the forecast period.

The use of combination drugs for the treatment of asthma and COPD is increasing. This is due to the greater impact on patient-reported outcomes (PROs) compared to monotherapies. For example, a combination of short-acting beta-agonists (SABA) and short-acting muscarinic antagonists (SAMA) is superior compared to either medication alone in improving lung function. The use of a combination of long-acting beta-agonists (LABA), and long-acting muscarinic antagonists (LAMA) have improved lung function than long-acting monotherapy bronchodilators.

Many inhalers that do not use chlorofluorocarbons (CFC) are already available for the treatment of asthma and chronic obstructive pulmonary disease. These products aren't necessarily official direct alternatives to CFC Metered Dose Inhalers, but may in many patients serve as a useful medication that could replace the need for a particular CFC Metered Dose Inhaler. FDA will determine official alternatives by using the criteria established through notice-and-comment rulemaking.

North America was the largest region in the anti-asthmatics and COPD drugs market in 2022. Middle East is expected to be the fastest-growing region in the global anti-asthmatics and copd drugs market during the forecast period. The regions covered in the global anti-asthmatics and COPD drugs market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the anti-asthmatics and COPD drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The anti-asthmatic and chronic obstructive pulmonary disease market consists of corticosteroid, bronchodilator, fluticasone and salmeterol. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market research report are one of a series of new reports from The Business Research Company that provides anti-asthmatics and chronic obstructive pulmonary disease (COPD) market statistics, including anti-asthmatics and chronic obstructive pulmonary disease (COPD) industry global market size, regional shares, competitors with an anti-asthmatics and chronic obstructive pulmonary disease (COPD) market share, detailed anti-asthmatics and chronic obstructive pulmonary disease (COPD) market segments, market trends and opportunities, and any further data you may need to thrive in the anti-asthmatics and chronic obstructive pulmonary disease (COPD) industry. These anti-asthmatics and chronic obstructive pulmonary disease (COPD) market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    Table 1: Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis

    Table 2: Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2020

    Table 3: Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2020

    Table 4: Anti-Asthmatics And COPD Drugs Market Regulatory Landscape

    Table 5: Prevalence Of Asthma, 2015-2019

    Table 6: Prevalence Of COPD, 2015-2019

    Table 7: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 8: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 9: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 10: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 11: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 12: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 13: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020

    Table 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020

    Table 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2020

    Table 22: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020

    Table 23: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020

    Table 24: Asia Pacific GDP Per Capita, 2015-2020, $

    Table 25: Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands

    Table 26: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion

    Table 27:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 28: Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 29: Air Pollution And Air Quality Index, Asia-Pacific Countries

    Table 30: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 31: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 32: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 33: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 34: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 35: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 36: China GDP Per Capita, 2015-2020, $

    Table 37: China, Population By Age Group, 2015-2023, Thousands

    Table 38:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 39: China Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 40: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 41: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 42: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 43: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 44: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 45: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Millio

    Table 46: India GDP Per Capita, 2015-2020, $

    Table 47: India, Population By Age Group, 2015-2023, Thousands

    Table 48:  India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 49: India Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 50: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 51: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 52: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 53: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 54: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 55: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 56: Japan GDP Per Capita, 2015-2020, $

    Table 57: Japan, Population By Age Group, 2015-2023, Thousands

    Table 58:  Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 59: Japan Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 60: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 61: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 62: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 63: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 64: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 65: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 66: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 67: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 68: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 69: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 70: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 71: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 72: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 73: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 74: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 75: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 76: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 77: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 78: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 79: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 80: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 81: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 82: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 83: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 84: Western Europe GDP Per Capita, 2015-2020, $

    Table 85: Western Europe, Population By Age Group, By Country, 2015-2023, Thousands

    Table 86:  Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion

    Table 87:  Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 88: Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 89: Air Pollution And Air Quality Index in 2018, Western Europe Countries

    Table 90: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 91: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 92: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 93: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 94: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 95: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 96: UK GDP Per Capita, 2015-2020, $

    Table 97: UK, Population By Age Group, 2015-2023, Thousands

    Table 98:  UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 99: UK Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 100: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 101: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 102: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 103: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 104: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 105: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 106: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 107: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 108: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 109: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 110: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 111: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 112: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 113: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 114: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 115: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 116: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 117: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 118: Eastern Europe GDP Per Capita, 2015-2020, $

    Table 119: Eastern Europe, Population By Age Group, By Country, 2015-2023, Thousands

    Table 120:  Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion

    Table 121:  Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 122: Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 123: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 124: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 125: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 126: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 127: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 128: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 129: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 130: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 131: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 132: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 133: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 134: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 135: North America GDP Per Capita, 2015-2020, $

    Table 136: North America, Population By Age Group, By Country, 2015-2023, Thousands

    Table 137:  North America Public Healthcare Expenditure, 2015-2019, $ Billion

    Table 138:  North America Private Healthcare Expenditure, 2013-2017, $ Billion

    Table 139: North America Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 140: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 141: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 142: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 143: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 144: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 145: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 146: USA GDP Per Capita, 2015-2020, $

    Table 147: USA, Population By Age Group, 2015-2023, Thousands

    Table 148:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 149: USA Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 150: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 151: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 152: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 153: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 154: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 155: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 156: South America GDP Per Capita, 2015-2020, $

    Table 157: South America, Population By Age Group, By Country, 2015-2023, Thousands

    Table 158:  South America Public Healthcare Expenditure, 2015-2019, $ Billion

    Table 159:  South America Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 160: South America Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 161: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 162: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 163: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 164: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 165: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 166: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 167: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 168: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 169: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 170: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 171: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 172: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 173: Middle East GDP Per Capita, 2015-2020, $

    Table 174: Middle East, Population By Age Group, By Country, 2015-2023, Thousands

    Table 175:  Middle East Public Healthcare Expenditure, 2015-2019, $ Billion

    Table 176:  Middle East Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 177: Middle East Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 178: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 179: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 180: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 181: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 182: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 183: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 184: Africa GDP Per Capita, 2015-2020, $

    Table 185: Africa, Population By Age Group, By Country, 2015-2023, Thousands

    Table 186:  Africa Public Healthcare Expenditure, 2015-2019, $ Billion

    Table 187:  Africa Private Healthcare Expenditure, 2015-2019, $ Billion

    Table 188: Africa Total Population Aged 65 And Above, 2015-2023, Thousands

    Table 189: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

    Table 190: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

    Table 191: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 192: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 193: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

    Table 194: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

    Table 195: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

    Table 196: GlaxoSmithKline – Financial Overview, 2016 - 2020, $ Billion

    Table 197: AstraZeneca plc. –  Financial Overview, 2016 - 2020, $ Billion

    Table 198: Boehringer Ingelheim GmbH – Financial Overview, 2016 - 2020, $ Billion

    Table 199: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion

    Table 200: Novartis AG – Financial Overview, 2016 - 2020, $ Billion

    Table 201: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion

    Table 202: Global Respiratory Diseases Drugs Market, 2020, Split By Region

    Table 203: Global Respiratory Diseases Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region

    Table 204: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2020 – 2025, By Country

    Table 205: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Drug Class, 2020 – 2025

    Table 206: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By End Users, 2020 – 2025

    Table 207: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025

    Table 208: Anti-Asthmatics And COPD Drugs - Market Data Sources

List Of Tables

    Table 1: Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
  • Table 2: Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2020
  • Table 3: Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2020
  • Table 4: Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
  • Table 5: Prevalence Of Asthma, 2015-2019
  • Table 6: Prevalence Of COPD, 2015-2019
  • Table 7: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 8: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 9: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 12: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 13: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020
  • Table 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020
  • Table 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2020
  • Table 22: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020
  • Table 23: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020
  • Table 24: Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 25: Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 26: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 27:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 28: Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 29: Air Pollution And Air Quality Index, Asia-Pacific Countries
  • Table 30: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 31: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 32: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 33: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 34: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 35: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 36: China GDP Per Capita, 2015-2020, $
  • Table 37: China, Population By Age Group, 2015-2023, Thousands
  • Table 38:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 39: China Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 40: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 41: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 42: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 43: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 44: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 45: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Millio
  • Table 46: India GDP Per Capita, 2015-2020, $
  • Table 47: India, Population By Age Group, 2015-2023, Thousands
  • Table 48:  India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 49: India Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 50: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 51: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 52: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 53: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 54: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 55: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 56: Japan GDP Per Capita, 2015-2020, $
  • Table 57: Japan, Population By Age Group, 2015-2023, Thousands
  • Table 58:  Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 59: Japan Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 60: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 61: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 62: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 63: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 64: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 65: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 66: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 67: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 68: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 69: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 70: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 71: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 72: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 73: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 74: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 75: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 76: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 77: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 78: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 79: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 80: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 81: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 82: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 83: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 84: Western Europe GDP Per Capita, 2015-2020, $
  • Table 85: Western Europe, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 86:  Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 87:  Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 88: Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 89: Air Pollution And Air Quality Index in 2018, Western Europe Countries
  • Table 90: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 91: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 92: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 93: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 94: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 95: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 96: UK GDP Per Capita, 2015-2020, $
  • Table 97: UK, Population By Age Group, 2015-2023, Thousands
  • Table 98:  UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 99: UK Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 100: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 101: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 102: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 103: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 104: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 105: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 106: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 107: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 108: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 109: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 110: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 111: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 112: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 113: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 114: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 115: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 116: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 117: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 118: Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 119: Eastern Europe, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 120:  Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 121:  Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 122: Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 123: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 124: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 125: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 126: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 127: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 128: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 129: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 130: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 131: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 132: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 133: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 134: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 135: North America GDP Per Capita, 2015-2020, $
  • Table 136: North America, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 137:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 138:  North America Private Healthcare Expenditure, 2013-2017, $ Billion
  • Table 139: North America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 140: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 141: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 142: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 143: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 144: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 145: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 146: USA GDP Per Capita, 2015-2020, $
  • Table 147: USA, Population By Age Group, 2015-2023, Thousands
  • Table 148:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 149: USA Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 150: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 151: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 152: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 153: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 154: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 155: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 156: South America GDP Per Capita, 2015-2020, $
  • Table 157: South America, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 158:  South America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 159:  South America Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 160: South America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 161: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 162: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 163: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 164: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 165: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 166: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 167: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 168: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 169: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 170: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 171: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 172: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 173: Middle East GDP Per Capita, 2015-2020, $
  • Table 174: Middle East, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 175:  Middle East Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 176:  Middle East Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 177: Middle East Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 178: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 179: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 180: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 181: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 182: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 183: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 184: Africa GDP Per Capita, 2015-2020, $
  • Table 185: Africa, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 186:  Africa Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 187:  Africa Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 188: Africa Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 189: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 190: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 191: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 192: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 193: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 194: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 195: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 196: GlaxoSmithKline – Financial Overview, 2016 - 2020, $ Billion
  • Table 197: AstraZeneca plc. –  Financial Overview, 2016 - 2020, $ Billion
  • Table 198: Boehringer Ingelheim GmbH – Financial Overview, 2016 - 2020, $ Billion
  • Table 199: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion
  • Table 200: Novartis AG – Financial Overview, 2016 - 2020, $ Billion
  • Table 201: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
  • Table 202: Global Respiratory Diseases Drugs Market, 2020, Split By Region
  • Table 203: Global Respiratory Diseases Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
  • Table 204: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 205: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Drug Class, 2020 – 2025
  • Table 206: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By End Users, 2020 – 2025
  • Table 207: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
  • Table 208: Anti-Asthmatics And COPD Drugs - Market Data Sources

List Of Figures

    Figure 1: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Class
  • Figure 2: Global Anti-Asthmatics And COPD Drugs Market Segmentation By End User
  • Figure 3: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Distribution Channel
  • Figure 4: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Therapy
  • Figure 5: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Route Of Administration
  • Figure 6: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Age Group
  • Figure 7: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Prescription
  • Figure 8: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Type
  • Figure 9: Market Supply Chain For Anti-Asthmatics And COPD Drugs
  • Figure 10: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 11: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 12: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 13: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020
  • Figure 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020
  • Figure 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2020
  • Figure 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020
  • Figure 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020
  • Figure 22: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 23: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 24: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 25: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 26: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 27: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 28: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 29: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 30: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 31: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 32: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 33: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 34: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 35: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 36: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 37: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 38: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 39: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 40: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 41: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 42: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 43: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 44: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 45: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 46: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 47: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 48: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 49: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 50: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 51: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 52: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 53: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 54: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 55: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 56: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 57: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 58: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 59: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 60: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 61: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 62: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 63: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 64: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 65: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 66: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 67: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 68: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 69: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 70: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 71: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 72: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 73: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 74: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 75: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 76: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 77: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 78: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 79: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 80: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 81: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 82: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 83: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 84: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 85: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 86: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 87: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 88: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 89: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 90: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 91: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 92: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 93: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 94: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 95: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 96: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 97: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 98: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 99: GlaxoSmithKline – Financial Overview, 2016 – 2020, $ Billion
  • Figure 100: AstraZeneca plc. – Financial Overview 2016 –  2020, $ Billion
  • Figure 101: Boehringer Ingelheim GmbH – Financial Overview, 2016 – 2020, $ Billion
  • Figure 102: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 – 2020, $ Billion
  • Figure 103: Novartis AG – Financial Overview, 2016 – 2020, $ Billion
  • Figure 104: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
  • Figure 105: Global Respiratory Diseases Drugs Market, 2020, Split By Region
  • Figure 106: Global Respiratory Diseases Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Anti-Viral Drug Therapy Market - By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies - Global Anti-Viral Drug Therapy Market Forecast To 2030
View Report
Influenza Diagnostic Global Market Report 2023 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests), By Molecular diagnostic tests (Reverse Transcription Polymerase Chain Reaction (RTPCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By EndUsers (Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032
View Report
Viral Vectors And Plasmid DNA Global Market Report 2023 – By Product (Plasmid DNA, Viral Vectors), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2023-2032
View Report
COVID-19 Drug Associated APIs Global Market Report 2023 – By Drug Class (Antimalarials, Bronchodilators, Antibiotics, Antivirals, Other Drug Class), By Synthesis Type (Synthetic, Biotech), By Business Mode (Captive API, Merchant API) – Market Size, Trends, And Global Forecast 2023-2032
View Report
COVID-19 Detection Test Kits and Consumables Global Market Report 2023 – By Kits (Viral Load Testing Kits (qPCR and RT-PCR), Virus Neutralizing Assay Kits, Antibody Detection Kits (Elisa), Viral Antigen Detection Test Kits, Other Kits), By Consumables (Swabs, Tubes, Viral Transfer Media, Reagents, Other Consumables), By Specimen Type (Nose & Throat Swab, Blood, Sputum, Nasal Aspirate), By End Use (Hospitals, Clinics, Public Health Labs, Private And Commercial Labs, Physicians Labs, Research Institutes, Other End Uses) – Market Size, Trends, And Global Forecast 2023-2032
View Report
Hospital Acquired Infections Testing Kits Global Market Report 2023 – By Product (Instrument & Reagents, Consumables), By Test Type (Pneumonia Infection, Urinary Tract Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA Infection, Other Test Types), By Application (Drug-resistance Testing, Disease Testing), By Pathogen Type (Viral, Bacterial, Fungal), By Method of Treatment (Sterilization, Chemical, Radiation) – Market Size, Trends, And Global Forecast 2023-2032
View Report
Anti-Infective Drugs Market - By Type (Antibiotics, Antivirals, Antifungals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Liposomal Drug Delivery Devices Global Market Report 2023 – By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types), By Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032
View Report